Clinical Trial

Diabetes Registry Graz for Biomarker Research

Study acronym: GIRO
Recruiting
View on ClinicalTrials.gov →
Summary
The Diabetes registry for biomarker research Graz is a prospective cohort-study including subjects with type 1 and type 2 diabetes, rare types of diabetes, obesity and dyslipidemia, aiming to collect data, blood and urine samples of all subjects on an annual basis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-04-05.
Trial Details
NCT Number NCT05324488
Lead Sponsor Medical University of Graz
Conditions Type1diabetes, Type 2 Diabetes, Adiposity
Enrollment 2,000 participants
Start Date 2015-10-21
Primary Completion 2035-01-01 (estimated)
Study Completion 2035-02-01 (estimated)
Updated on ClinicalTrials.gov 2023-07-07